High-strength CoQ10 now available
THE body is capable of producing its own supply of CoQ10, peaking at the age of 20. However, this capacity diminishes as we age. At the age of 40, the CoQ10 level in various parts of the body will drop by almost 40%
Cholesterol and CoQ10 are produced through the same pathway, so it is vital to top up the day with CoQ10 while taking a cholesterol lowering agent, as that will help provide optimum health protection
CoQ10 exists in two forms – ubiquinone and ubiquinol. Both are important and have their own distinctive functions, with ubiquinone playing a role in the energy production cycle while ubiquinol serves as a strong antioxidant.
The safety of high-strength CoQ10 in the form of ubiquinone has been well established through years of research
StemLabs CoQ10 300mg (MAL 16085008NCR) is a newly launched product that offers high-strength CoQ10 in the form of one-a-day ubiquinone capsules.
Produced naturally from yeast fermentation, the ubiquinone in StemLabs CoQ10 300mg maintains its natural fat-soluble characteristic.
Ubiquinone is stable in the stomach. Upon consumption, the body will convert it into ubiquinol form before circulating it throughout the body.
Although there is no specific dietary recommendation for CoQ10, 300mg is the strength used in studies to help improve certain health conditions
Benefits of StemLabs CoQ10 300mg
> Improves energy and stamina > Reduces fatigue and tiredness > Suitable for active lifestyle > Promotes physical performance and faster recovery from fatigue
> Rich in antioxidants
StemLabs CoQ10 300mg is manufactured in New Zealand and retails at a reasonable price without compromising its quality.
StemLabs takes the initiative to perform ongoing stability tests for all its products, fulfilling its promise of safe and quality products that benefit customers.
Kalen et al. 1989. Age-related changes in the lipid compositions of rat and human tissues. Lipids 24(7): 579584.
Lee et al. 2013. Effects of coenzyme Q10 supplementation (300mg/day) on antioxidant and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo controlled trials. Nutrition Journal 12:142.
Hathcock & Shao. 2006. Risk assessment for coenzyme Q10 (Ubiquinone). Regulatory Toxicology and Pharmacology 45(3): 282-288.
Mizuno et al. 2008. Antifatigue effect of coenzyme Q10 during physical fatigue. Nutrition 24(4): 293-299.
Belardinelli et al. 2006. Coenzyme Q10 and exercise training in chronic heart failure. European Heart Journal 27: 2675–2681.
Tiano et al. 2007. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. European Heart Journal 28(18):2249-225
For more information, contact the customer hotline at 1800 220 822.
This article is brought to you by Cellgen Lifesciences (M) Sdn Bhd.
This is a supplement product advertisement.